← Back to headlines
Experimental Nasal Vaccine for Tuberculosis Under Development
A new experimental nasal vaccine is being developed to target tuberculosis, specifically focusing on the bacteria's resilient defense mechanisms that allow it to survive treatment.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
